| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5685754 | American Journal of Kidney Diseases | 2016 | 10 Pages |
Abstract
High CVVHDF dose did not improve patient outcomes despite its significant influence on inflammatory cytokine removal. CRRT-induced immunomodulation may not be sufficient to influence clinical end points.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jung Tak MD, PhD, Hajeong MD, Youn Kyung MD, Seokwoo MD, Hyung Jung MD, Seung Hyeok MD, PhD, Kwon Wook MD, PhD, Chun-Soo MD, PhD, Yon Su MD, PhD, Shin-Wook MD, PhD, Tae-Hyun MD, PhD, Dong Ki MD, PhD,